Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 2,000 shares at $380.00 ($760K) on 2018-08-02, disclosed to the SEC on 2018-08-03.
Seasonal sale ($760k) by Director — this insider has traded REGN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |